Biocon Announces Floor Price of ₹387.74 Per Share for Qualified Institutions Placement

Biocon Limited, a leading biopharmaceutical company, has initiated its Qualified Institutions Placement (QIP) to raise capital for strategic initiatives. The floor price has been set at ₹387.74 per equity share, calculated in accordance with SEBI’s pricing formula. This move follows board and shareholder approvals, signaling Biocon’s intent to strengthen its financial base and fuel future growth.

Key Highlights

• Floor Price: ₹387.74 per equity share, based on SEBI’s prescribed formula.
• Discount Provision: Up to 5% discount may be offered, subject to shareholder approval.
• Approval Timeline: Shareholders approved the fundraising plan at the EGM held on December 31, 2025.
• Fundraising Committee: Authorized the QIP opening on January 12, 2026.
• Final Pricing: To be decided in consultation with book running lead managers.
• Strategic Intent: Funds will support Biocon’s expansion, innovation, and operational resilience.

Sources: FilingReader Intelligence, InvestyWise